title: Erythema gyratum repens as the initial manifestation of lung cancer.
authors.forename: Vasco
authors.initials: V
authors.lastname: Serrão
authors.forename: Andréa
authors.initials: A
authors.lastname: Martins
authors.forename: Pedro
authors.initials: P
authors.lastname: Ponte
authors.forename: Juliana
authors.initials: J
authors.lastname: Baptista
authors.forename: Margarida
authors.initials: M
authors.lastname: Apetato
authors.forename: Ana Barata
authors.initials: AB
authors.lastname: Feio
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001999:Bronchoscopy; D016190:Carboplatin / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004890:Erythema / Q000175:diagnosis* / Q000473:pathology; D005148:Facial Dermatoses / Q000175:diagnosis* / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D008297:Male; D010257:Paraneoplastic Syndromes / Q000175:diagnosis* / Q000473:pathology; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D016190:Carboplatin; D000077235:Vinorelbine